Navigation Links
China Kanghui Holdings Announces Shareholder Resolutions Adopted at 2011 Annual General Meeting
Date:9/6/2011

CHANGZHOU, China, Sept. 6, 2011 /PRNewswire-Asia/ -- China Kanghui Holdings (NYSE: KH) ("Kanghui" or the "Company"), a leading domestic developer, manufacturer and marketer of orthopedic implants in China, today announced that all shareholder resolutions proposed at the Company's 2011 annual general meeting held in Hong Kong on September 5, 2011 were duly adopted. Specifically, the shareholders passed resolutions approving:

  1. Re-election of Mr. Yikang Jiang as a Class A director of the Company.
  2. Re-election of Mr. Jun Du as a Class A director of the Company.
  3. Re-election of Ms. Shuchun Gao as a Class A director of the Company.
  4. Appointment of Ernst & Young Hua Ming as independent auditor of the Company for the fiscal year ending December 31, 2011.
  5. Amendment of the 2010 Share Incentive Plan to increase share limit.

Pursuant to the resolutions adopted, Mr. Yikang Jiang, Mr. Jun Du and Ms. Shuchun Gao were re-elected as Class A directors of the Company for a term of three years, Ernst & Young Hua Ming was appointed as independent auditor of the Company for the fiscal year ending December 31, 2011, and the share limit of the Company's the 2010 Share Incentive Plan was increased to 15,793,708 ordinary shares, representing approximately 9.29% of the Company's total outstanding shares on a fully diluted basis as of September 5, 2011.

About China Kanghui HoldingsFounded in 1997, Kanghui is a leading domestic developer, manufacturer and marketer of orthopedic implants in China. The Company offers a wide array of proprietary orthopedic implant products in trauma and spine. It has an extensive network of distributors for its products in China. In addition, Kanghui's products are distributed in 28 countries. Kanghui has strong research and development capabilities, focused on developing new proprietary products, including new product lines, extensions of existing product lines and enhancements of existing products. For more information, please visit www.kanghui.com.Contact:China Kanghui Holdings Investor Relations Department  +1-888-321-2558Asia Bridge Capital LimitedCarene Toh+86-186 1835 6339carene.toh@asiabridgegroup.com
'/>"/>

SOURCE China Kanghui Holdings
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. China Cord Blood Corporation Announces Participation in Upcoming Investor Conferences
2. Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets
3. China Botanic Pharmaceutical Enters into Research Cooperation with Key Laboratory of Forest Plant Ecology
4. China Nuvo Solar Target Acquisition SurgLine Reports on Marketing Progress
5. China Nepstar Chain Drugstore Announces Share Repurchase Program
6. China Nepstar Chain Drugstore Reports Second Quarter 2011 Financial Results
7. China Nepstar Chain Drugstore Announces Management Change
8. China Medicine Corporation Dismisses Frazer Frost as Auditor
9. VacChina 2011 - Bridging the China Vaccine Industry with the World Class Biotechnologies
10. China Contract Research Organization (CRO) Industry Report, 2010-2011
11. Abbott Expanding Manufacturing Capacity in China to Meet Demands of Fast-Growing Nutrition Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... DALLAS , April 19, 2017  Vanderbilt ... the first patients in Nashville , ... the Lower Esophageal Sphincter Stimulation for GERD (LESS GERD) ... designed to provide long-term reflux control by restoring normal ... affects nearly 65 million people in the ...
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, ... antibody-centric, clinical-stage biopharmaceutical company developing new treatments for ... the closing of its previously announced underwritten public ... at a public offering price of $2.00 per ... estimated offering expenses payable by Sorrento.  The net ...
(Date:4/19/2017)... April 19, 2017  New research provides evidence that an ... according to a study released today that will be presented ... in Boston , April 22 to ... treatment of Parkinson,s disease, the oral drug levodopa has long ... longevity. But as the disease progresses, the effects of the ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... 28, 2017 , ... Semrock’s highly popular SearchLight Spectra Viewer ... resource for fluorescence microscopists and optical system designers, enabling The Right Solution, Right ... the globe, SearchLight has become a tremendously popular tool for the fluorescence imaging ...
(Date:4/27/2017)... ... April 27, 2017 , ... Thinksport, the leaders in safe, ... award-winning sunscreen they’ve used the same scientific approach to solving smelly, sweaty athletes, ... the aisles that contain harmful chemicals that should be put nowhere near your ...
(Date:4/27/2017)... ... April 27, 2017 , ... Offering the purest product of its ... times purer and more potent than the market has seen before. Swissx uses proprietary ... well as a patented chromatography process for extraction, to produce its CBD oil--maximizing its ...
(Date:4/26/2017)... , ... April 26, 2017 , ... Journal of ... It can have severe consequences to overall dental health, including complications with speech, eating, ... turn to dental implants to replace lost teeth. As the number of tooth replacements ...
(Date:4/26/2017)... ... April 26, 2017 , ... The ... Excellence upon National Registry of Emergency Medical Technicians and welcomes this ... said Dr. Jan G. West, Ph.D. , CEO & Organizational Psychologist at ...
Breaking Medicine News(10 mins):